Vaccination targeting the novel endogenous tumor-associated antigen Gpr149 induces protective immunity against checkpoint inhibitor-refractory SB28 glioblastoma
Emily E Steffke, Taijun Hana, Laila Latifi, Sara Abdel Malak, James McAuliffe, Vinnycius Pereira Almeida, Nicole Briceno, Meili Zhang, Dionne L. Davis, Wei Zhang, Hua Song, Michael E. Bryan, Hye Kim, Mark R. Gilbert, Hideho Okada, , Masaki Terabe
This study identifies Gpr149 as an endogenous antigen in SB28 glioblastoma that can be targeted by vaccination to induce protective immunity against checkpoint inhibitor-refractory tumors.
bioRxiv · Oct 30, 2026 · PreprintImmunology